Pfizer to challenge Indian ruling overturning cancer drug patent Economic Times The patent office's decision went to the heart of India's patent act, which says a patent cannot be granted for a drug unless changes make it significantly more effective and innovative. "The patentee (Pfizer) has miserably failed to demonstrate any ... |
